Skip to content

Use of Electroconvulsive Therapy (ECT) in Chronic, Severe, Treatment Resistant Posttraumatic Stress Disorder

Efficacy of ECT in Chronic, Severe, Antidepressant- And CBT-Refractory Posttraumatic Stress Disorder: An Open, Prospective Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00739856
Enrollment
20
Registered
2008-08-22
Start date
2005-01-31
Completion date
Unknown
Last updated
2008-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder

Keywords

posttraumatic stress disorder, electroconvulsive therapy, medication refractoriness

Brief summary

Post Traumatic Stress Disorder is a chronic debilitating illness and few treatment options have demonstrated effectiveness. The study will look at the use of electroconvulsive therapy for the treatment of Post Traumatic Stress disorder in patients who have not responded to multiple antidepressants or cognitive behavioral therapy.

Interventions

PROCEDUREElectroconvulsive Therapy

ECT was administered using the MECTA-SR1 apparatus. The current amplitude was 800 mA, pulse width was 1.5 ms, and pulse frequency was 50 Hz. Stimulus duration was increased as required to elicit an adequate seizure, defined as at least 25 s with EEG monitoring. The ECT course was fixed, and comprised 6 treatments administered with bitemporal electrode placement at a twice-weekly frequency

Sponsors

Government Psychiatric Diseases Hospital, Srinagar
CollaboratorUNKNOWN
Government Medical College Srinagar
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of PTSD * Treatment resistance to 4 different antidepressants from 3 different classes * Treatment resistance to CBT * Severe PTSD

Exclusion criteria

* Significant substance abuse * Pregnancy * History of Traumatic Brain Injury * Unstable comorbid medical illness * Organic brain syndrome

Design outcomes

Primary

MeasureTime frame
Clinician-Administered Posttraumatic Stress Disorder Scale (CAPS) SCORE

Secondary

MeasureTime frame
Montgomery-Asberg Depression Rating Scale scorebaseline, 48 hrs post 3rd, 6th ECT

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026